Identification of novel neuroendocrine-specific tumour genes
E Hofsli1, T E Wheeler, M Langaas
1Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway. eva.hofsli@stolav.no
Abstract:
Neuroendocrine tumours (NETs) comprise a heterogenous group of malignancies with an often unpredictable course, and with limited treatment options. Thus, new diagnostic, prognostic, and therapeutic markers are needed. To shed new lights into the biology of NETs, we have by cDNA transcript profiling, sought to identify genes that are either up- or downregulated in NE as compared with non-NE tumour cells. A panel of six NET and four non-NET cell lines were examined, and out of 12 743 genes examined, we studied in detail the 200 most significantly differentially expressed genes in the comparison. In addition to potential new diagnostic markers (NEFM, CLDN4, PEROX2), the results point to genes that may be involved in the tumorigenesis (BEX1, TMEPAI, FOSL1, RAB32), and in the processes of invasion, progression and metastasis (MME, STAT3, DCBLD2) of NETs. Verification by real time qRT-PCR showed a high degree of consistency to the microarray results. Furthermore, the protein expression of some of the genes were examined. The results of our study has opened a window to new areas of research, by uncovering new candidate genes and proteins to be further investigated in the search for new prognostic, predictive, and therapeutic markers in NETs.
Insights
Researchers identified new genes and proteins in neuroendocrine tumors (NETs) by analyzing gene expression. These findings could lead to better diagnostic, prognostic, and therapeutic markers for NETs.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Neuroendocrine tumors (NETs) are a diverse group of cancers with unpredictable progression and limited treatment options.
- There is a critical need for novel diagnostic, prognostic, and therapeutic markers in NETs.
- Understanding the molecular underpinnings of NETs is essential for developing targeted therapies.
Purpose of the Study:
- To identify novel genes and proteins differentially expressed in neuroendocrine tumors (NETs) compared to non-NET cells.
- To uncover potential biomarkers for diagnosis, prognosis, and treatment of NETs.
- To explore the biological pathways involved in NET tumorigenesis and progression.
Main Methods:
- Utilized cDNA transcript profiling (microarray analysis) on a panel of six NET and four non-NET cell lines.
- Analyzed the expression of 12,743 genes, focusing on the 200 most significantly differentially expressed.
- Validated findings using real-time quantitative reverse transcription PCR (qRT-PCR) and examined protein expression.
Main Results:
- Identified potential diagnostic markers including NEFM, CLDN4, and PEROX2.
- Discovered genes implicated in NET tumorigenesis (BEX1, TMEPAI, FOSL1, RAB32) and metastasis (MME, STAT3, DCBLD2).
- Microarray results were consistently validated by qRT-PCR, indicating high reliability.
Conclusions:
- The study identified novel candidate genes and proteins for further investigation in NETs.
- These findings open new avenues for research into prognostic, predictive, and therapeutic markers for NETs.
- The uncovered molecular targets may improve the clinical management of neuroendocrine tumors.
More Related Videos
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...